Literature DB >> 29022161

POM-1 inhibits P2 receptors and exhibits anti-inflammatory effects in macrophages.

Gabriela Pimenta-Dos-Reis1, Eduardo José Lopes Torres2, Paula Gabriela Quintana1, Lincon Onorio Vidal1, Bárbara Andréa Fortes Dos Santos1, Chuan-Sheng Lin3,4, Norton Heise1, Pedro Muanis Persechini1, Julieta Schachter5,6.   

Abstract

Extracellular nucleotides can modulate the immunological response by activating purinergic receptors (P2Rs) on the cell surface of macrophages, dendritic, and other immune cells. In particular, the activation of P2X7R can induce release of cytokines and cell death as well as the uptake of large molecules through the cell membrane by a mechanism still poorly understood. Polyoxotungstate-1 (POM-1) has been proposed as a potent inhibitor of ecto-nucleotidases, enzymes that hydrolyze extracellular nucleotides, regulating the activity of P2Rs. However, the potential impact of POM-1 on P2Rs has not been evaluated. Here, we used fluorescent dye uptake, cytoplasmic free Ca2+ concentration measurement, patch-clamp recordings, scanning electron microscopy, and quantification of inflammatory mediators to investigate the effects of POM-1 on P2Rs of murine macrophages. We observed that POM-1 blocks the P2YR-dependent cytoplasmic Ca2+ increase and has partial effects on the cytoplasmic Ca2+, increasing dependence on P2XRs. POM-1 can inhibit the events related with ATP-dependent inflammasome activation, anionic dye uptake, and also the opening of large conductance channels, which are associated with P2X7R-dependent pannexin-1 activation. On the other hand, this compound has no effects on cationic fluorescent dye uptake, apoptosis, and bleb formation, also dependent on P2X7R. Moreover, POM-1 can be considered an anti-inflammatory compound, because it prevents TNF-α and nitric oxide release from LPS-treated macrophages.

Entities:  

Keywords:  ATP; Inflammation; Macrophage; POM-1; Purinergic receptor

Mesh:

Substances:

Year:  2017        PMID: 29022161      PMCID: PMC5714851          DOI: 10.1007/s11302-017-9588-x

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  73 in total

Review 1.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

2.  Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors.

Authors:  Amanda B Mackenzie; Mark T Young; Elena Adinolfi; Annmarie Surprenant
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

Review 3.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

Review 4.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins.

Authors:  Peter J Hanley; Moritz Kronlage; Carsten Kirschning; Adriana del Rey; Francesco Di Virgilio; Jens Leipziger; Iain P Chessell; Sarah Sargin; Mikhail A Filippov; Otto Lindemann; Simon Mohr; Volker Königs; Hermann Schillers; Martin Bähler; Albrecht Schwab
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

7.  Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages.

Authors:  Robson Coutinho-Silva; David M Ojcius; Darek C Górecki; Pedro M Persechini; Rodrigo C Bisaggio; Anderson N Mendes; Joanne Marks; Geoffrey Burnstock; Philip M Dunn
Journal:  Biochem Pharmacol       Date:  2005-01-12       Impact factor: 5.858

8.  Insulin mimetic effect of a tungstate cluster. Effect of oral administration of homo-polyoxotungstates and vanadium-substituted polyoxotungstates on blood glucose level of STZ mice.

Authors:  K Nomiya; H Torii; T Hasegawa; Y Nemoto; K Nomura; K Hashino; M Uchida; Y Kato; K Shimizu; M Oda
Journal:  J Inorg Biochem       Date:  2001-10       Impact factor: 4.155

9.  Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism.

Authors:  Zhongshuang Hu; Taisuke Murakami; Kaori Suzuki; Hiroshi Tamura; Kyoko Kuwahara-Arai; Toshiaki Iba; Isao Nagaoka
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

10.  Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor.

Authors:  Hayato Sakaki; Mitsutoshi Tsukimoto; Hitoshi Harada; Yoshinori Moriyama; Shuji Kojima
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more
  3 in total

1.  Whipworm Infection Promotes Bacterial Invasion, Intestinal Microbiota Imbalance, and Cellular Immunomodulation.

Authors:  Julieta Schachter; Dayane Alvarinho de Oliveira; Camila Marques da Silva; Alba Cristina Miranda de Barros Alencar; Michelle Duarte; Matheus Müller Pereira da Silva; Ana Claudia de Paula Rosa Ignácio; Eduardo José Lopes-Torres
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 2.  Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

Authors:  Yue Lang; Fengna Chu; Donghui Shen; Weiguanliu Zhang; Chao Zheng; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

3.  Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer.

Authors:  Jasmine M Manouchehri; Jharna Datta; Natalie Willingham; Robert Wesolowski; Daniel Stover; Ramesh K Ganju; William E Carson; Bhuvaneswari Ramaswamy; Mathew A Cherian
Journal:  Front Oncol       Date:  2022-04-20       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.